Affiliate sale notice: Vertex (NASDAQ: VRTX) lists multiple common-share lots

Rhea-AI Filing Summary

Vertex Pharmaceuticals (common stock) reported a Form 144 notice showing proposed sales of common shares by an affiliate on various dates in 2026. The filing lists multiple lots tied to restricted stock vesting and option exercises, including 3,187; 4,318; 2,603; 23,479; and 25,026 shares on 02/10/2026, 02/13/2026, 02/17/2026, and 02/19/2026.

The notice names Fidelity Brokerage Services LLC and references NASDAQ; it reports the security type as Common and identifies several sale methods (vested restricted stock and option-related cash transactions). This is a routine affiliate sale notice under Rule 144; timing and exact sale mechanics depend on the holder's execution of the listed transactions.

Insights

Securities Counsel

Routine Rule 144 notice listing multiple lots tied to vesting and option exercises.

The filing lists proposed sales of Common shares associated with restricted stock vesting and option-related transactions dated 02/10/2026 through 02/19/2026. The notice names Fidelity Brokerage Services LLC as the brokerage address shown.

Execution depends on the selling holder's actions and Rule 144 conditions; the filing itself is a disclosure of intent to sell, not a confirmation of completed open-market trades. Subsequent sale confirmations or broker reports would show actual proceeds and timing.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	58613	27479575.82	254034190	02/19/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	02/10/2026	Restricted Stock Vesting	Issuer			3187	02/10/2026	Compensation
Common	02/13/2026	Restricted Stock Vesting	Issuer			4318	02/13/2026	Compensation
Common	02/17/2026	Restricted Stock Vesting	Issuer			2603	02/17/2026	Compensation
Common	02/19/2026	Option Granted - 02/06/2018	Issuer			23479	02/19/2026	Cash
Common	02/19/2026	Option Granted - 02/06/2019	Issuer			25026	02/19/2026	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does Vertex's (VRTX) Form 144 disclose?

The Form 144 discloses proposed sales of common stock by an affiliate on specific dates in 2026. It lists lots tied to restricted stock vesting and option exercises, including specific share counts for several lots.

Who is listed as the broker in the VRTX Form 144?

The filing lists Fidelity Brokerage Services LLC at 900 Salem Street, Smithfield, RI. This is the broker address shown in the notice for the proposed sales on 02/19/2026.

How many shares are included in the example lots on the Form 144?

The notice lists example lots of common shares including 3,187, 4,318, 2,603, 23,479, and 25,026 tied to dates between 02/10/2026 and 02/19/2026.

Does the Form 144 confirm the shares were sold?

No. The Form 144 is a notice of intent to sell under Rule 144; it does not confirm completion. Actual sales, prices, and proceeds are not reported in this excerpt.

Are the listed transactions company grants or holder sales in VRTX's filing?

The filing ties listed lots to restricted stock vesting and earlier option grants (dates shown), indicating the lots arise from compensation vesting or option exercises and are being presented for resale.